Ready-to-use therapeutic foods (RUTF), dosed by body weight, are the basis of treatment for uncomplicated severe acute malnutrition. Weight gain is the main way to monitor the effectiveness of such therapies. Previous reporting claimed that a lower-than-recommended dose of RUTF led to no less weight gain than the standard dose. This study was designed to examine that reporting and investigate the composition of gained mass based on this differential. The authors found there was no significant difference in tissue accretion in the lower dose of RUTF than in the standard dose.